Yttrium aluminum garnet laser capsulotomy after cataract surgery is tied to an increased risk for the progression of nonproliferative diabetic retinopathy and development of other serious eye issues. Medscape Medical News
Uncategorized
MCO-010 shows visual acuity gain in Stargardt disease at 48 weeks
ORLANDO — At 48 weeks, MCO-010, an optogenetic therapy, demonstrated gains in visual acuity in Stargardt disease, according to a study presented at the American Academy of Ophthalmology meeting.Kenneth C. Fan, MD, MBA, of Retina Consultants of Texas, t…
AAO 2025: Evolving Approaches in Retinal Disorders
Dr Sunir Garg shares insights on patient management, medication impact, and advancing technologies that are shaping the future of eye health. Medscape
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (“STAAR” o…
Uncategorized
Anterior migration possible with Ozurdex
Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed to development of macular edema due to retinal vein occlusion, noninfectious uveitis or diabetes.The implant, from AbbVie, gradually releases…
Uncategorized
Anterior migration possible with Ozurdex
Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed to development of macular edema due to retinal vein occlusion, noninfectious uveitis or diabetes.The implant, from AbbVie, gradually releases…